Aspects and issues of marketing authorisation and use of medicinal products for COVID-19 prevention during the pandemic

At the end of 2019, an outbreak of a new coronavirus began in the city of Wuhan (Hubei Province) in the People's Republic of China. The outbreak turned into a pandemic. In the shortest possible time, national and international manufacturers developed preventive COVID-19 vaccines, and the popula...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Soldatov, D. V. Gorenkov, V. A. Merkulov, V. P. Bondarev
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2022-12-01
Series:Биопрепараты: Профилактика, диагностика, лечение
Subjects:
Online Access:https://www.biopreparations.ru/jour/article/view/465
Tags: Add Tag
No Tags, Be the first to tag this record!